Literature DB >> 22185670

Oxadiazoles in medicinal chemistry.

Jonas Boström1, Anders Hogner, Antonio Llinàs, Eric Wellner, Alleyn T Plowright.   

Abstract

Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22185670     DOI: 10.1021/jm2013248

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  61 in total

1.  Multistep Synthesis of 1,2,4-Oxadiazoles via DNA-Conjugated Aryl Nitrile Substrates.

Authors:  Huang-Chi Du; Madison C Bangs; Nicholas Simmons; Martin M Matzuk
Journal:  Bioconjug Chem       Date:  2019-04-10       Impact factor: 4.774

2.  Automated molecule editing in molecular design.

Authors:  Peter W Kenny; Carlos A Montanari; Igor M Prokopczyk; Fernanda A Sala; Geraldo Rodrigues Sartori
Journal:  J Comput Aided Mol Des       Date:  2013-09-04       Impact factor: 3.686

3.  Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.

Authors:  Neeraj N Patwardhan; Emily A Morris; Yugesh Kharel; Mithun R Raje; Ming Gao; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2015-02-13       Impact factor: 7.446

4.  Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.

Authors:  Kaitlin J Basham; Vasudev R Bhonde; Collin Kieffer; James B C Mack; Matthew Hess; Bryan E Welm; Ryan E Looper
Journal:  Bioorg Med Chem Lett       Date:  2014-04-13       Impact factor: 2.823

5.  Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors.

Authors:  Shipeng He; Guoqiang Dong; Zhibin Wang; Wei Chen; Yahui Huang; Zhengang Li; Yan Jiang; Na Liu; Jianzhong Yao; Zhenyuan Miao; Wannian Zhang; Chunquan Sheng
Journal:  ACS Med Chem Lett       Date:  2015-01-14       Impact factor: 4.345

Review 6.  Bacterial proteolytic complexes as therapeutic targets.

Authors:  Ravikiran M Raju; Alfred L Goldberg; Eric J Rubin
Journal:  Nat Rev Drug Discov       Date:  2012-10       Impact factor: 84.694

7.  Structural Requirements and Docking Analysis of Amidine-Based Sphingosine Kinase 1 Inhibitors Containing Oxadiazoles.

Authors:  Joseph D Houck; Thomas K Dawson; Andrew J Kennedy; Yugesh Kharel; Niels D Naimon; Saundra D Field; Kevin R Lynch; Timothy L Macdonald
Journal:  ACS Med Chem Lett       Date:  2016-03-01       Impact factor: 4.345

8.  Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.

Authors:  Md Toufiqur Rahman; Ann M Decker; Tiffany L Langston; Kelly M Mathews; Lucas Laudermilk; Rangan Maitra; Weiya Ma; Emmanuel Darcq; Brigitte L Kieffer; Chunyang Jin
Journal:  J Med Chem       Date:  2020-11-18       Impact factor: 7.446

9.  Design, synthesis and characterization of novel 1,2-benzisothiazol-3(2H)-one and 1,3,4-oxadiazole hybrid derivatives: potent inhibitors of Dengue and West Nile virus NS2B/NS3 proteases.

Authors:  Huiguo Lai; Dengfeng Dou; Sridhar Aravapalli; Tadahisa Teramoto; Gerald H Lushington; Tom M Mwania; Kevin R Alliston; David M Eichhorn; Radhakrishnan Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

10.  Search for α3β₂/₃γ2 subtype selective ligands that are stable on human liver microsomes.

Authors:  Ojas A Namjoshi; Zhi-jian Wang; Sundari K Rallapalli; Edward Merle Johnson; Yun-Teng Johnson; Hanna Ng; Joachim Ramerstorfer; Zdravko Varagic; Werner Sieghart; Samarpan Majumder; Bryan L Roth; James K Rowlett; James M Cook
Journal:  Bioorg Med Chem       Date:  2012-11-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.